ABIOMED

Abiomed is a provider of mechanical circulatory support devices and offers a continuum of care to heart failure patients. The Company develops, manufacture and market products that is designed to enable the heart to rest, heal and recover by improving blood flow and/or performing the pumping function of the heart. The Company's products are used in the cardiac catheterization lab (cath lab) by interventional cardiologists and in the heart surgery suite by heart surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty or heart surgery procedures.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Abiomed (ABMD) closed at $256.28 in the latest trading session, marking a +1.9% move from the prior day.

Abiomed (ABMD) Outpaces Stock Market Gains: What You Should Know

Abiomed offers a niche product to a market that is experiencing phenomenal growth metrics.

Abiomed: Keeps The Heart And Your Portfolio Pumping

In the latest trading session, Abiomed (ABMD) closed at $270.08, marking a -0.67% move from the previous day.

Abiomed (ABMD) Stock Sinks As Market Gains: What You Should Know

Align Technology

DexCom

Intuitive Surgical

Tandem Diabetes Care

Medical device stocks were hot in 2018. Here's which ones could sizzle in 2019.

5 Top Medical Device Stocks for 2019

AAON

Darden Restaurants

Heidrick & Struggles International

SeaWorld Entertainment

U.S. hiring sprang back in March, with nonfarm payrolls expanding by 196,000 and the unemployment rate holding steady at 3.8%.

5 Top Stocks to Gain From Blowout Jobs Report

The stock of the fast-growing maker of temporary heart pumps remains a big winner over the past three years.

Why Abiomed Stock Fell 15% in March

Boeing

Markets ended the session mostly higher on Thursday as trade talks between the United States and China likely entered its final round.

Stock Market News For Apr 5, 2019

ABIOMED plans to expand products like Impella CP, Impella Connect, Impella 5.5 and Impella RP.

ABIOMED Impella Data Show Significant Rise in Survival Rates

Abiomed (ABMD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

All You Need to Know About Abiomed (ABMD) Rating Upgrade to Buy

Despite cutthroat competition in the niche markets, ABIOMED seems to be well-positioned for growth on strong guidance and solid product portfolio.

Here's Why You Should Retain ABIOMED Stock in Your Portfolio

In the latest trading session, Abiomed (ABMD) closed at $285.59, marking a +0.6% move from the previous day.

Abiomed (ABMD) Gains But Lags Market: What You Should Know

Medical technology stocks hit record highs last year and are spiking in 2019. Four of the fastest growing among them have tacked on double-digit earnings growth for several years.

Why These Fast-Growing Stocks Should Be On Your Radar: Abiomed

News for ABIOMED Stock (ABMD)